Wird geladen...
Recurrent Glioblastoma: Where we stand
Current first-line treatment regimens combine surgical resection and chemoradiation for Glioblastoma that provides a slight increase in overall survival. Age on its own should not be used as an exclusion criterion of glioblastoma multiforme (GBM) treatment, but performance should be factored heavily...
Gespeichert in:
| Veröffentlicht in: | South Asian J Cancer |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772393/ https://ncbi.nlm.nih.gov/pubmed/26981507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.175953 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|